24 min listen
Avedro CEO Reza Zadno Walks Us Through the Recent IPO, Reimbursement Wins, and Future Potential
Avedro CEO Reza Zadno Walks Us Through the Recent IPO, Reimbursement Wins, and Future Potential
ratings:
Length:
32 minutes
Released:
Apr 24, 2019
Format:
Podcast episode
Description
Avedro Inc. went public on Feb. 14, raising $70 million with its shares pricing at, coincidentally, $14. We talk with Reza Zadno, CEO and president, about the IPO process, which, as you might imagine, she says is as difficult as it looks. We’ll also talk business. Avedro, of course, is a commercial enterprise now, reporting growing sales on its Corneal Crosslinking System that can be used to treat keratoconus, a non-inflammatory eye condition that weakens and misshapes the cornea. What does the future hold for the start-up?
Released:
Apr 24, 2019
Format:
Podcast episode
Titles in the series (100)
Hear How Avedro’s Muller Is Building A Cross-Linking Powerhouse by OIS Podcast | Ophthalmology's leading Podcast